Bold claim: A nearly 50-year-old Pink Floyd track is quietly reshaping how we think about brain science. And yes, this controversy-worthy link is not just a neat coincidence—it's turning heads in two labs, across two countries, chasing distinct breakthroughs with the same song.
Two independent teams, one iconic tune, two very different scientific goals.
In 2023, researchers at UC Berkeley managed to reconstruct a recognizable version of Pink Floyd’s “Another Brick in the Wall, Part 1” using only brain activity data. The track, long esteemed by audiophiles for its pristine production, served as a musical touchstone for deciphering how the brain encodes complex sounds.
Two years later, a separate group at the Technion in Israel did something quite different: they played the same song to neurons in a dish, then to live mice. Their experiments revealed that low-frequency sound boosted mRNA gene expression by about tenfold, suggesting that gentle bass vibrations can influence cellular activity in meaningful ways.
Two labs, two nations, two distinct aims, yet the same classic track kept pulling researchers back.
What’s the secret about this almost half-century-old piece that keeps drawing scientific curiosity?
How Pink Floyd’s Low Frequencies Shape Brain Cells
Researchers Avi Schroeder and Patricia Mora-Raimundo from the Technion conducted a December 2025 study published in the Journal of Controlled Release. They explored how sound interacts with lipid nanoparticle (LNP) delivery, first in cultured neurons and then in mice, to see if auditory stimuli can modulate cellular uptake and gene expression.
They compared four categories of sound:
- Low-frequency tones (10–250 Hz) produced the strongest responses.
- Mid-frequency sounds (160–3,800 Hz) yielded modest gains.
- High-frequency sounds (1,250–22,000 Hz) underperformed compared with low frequencies.
- A Pink Floyd excerpt (roughly 128–5,600 Hz) increased expression too, likely because it combines a solid low-frequency base with musical complexity.
The takeaway: the bass end of the spectrum appears to be the most biologically active in this context. Even when the stimulus is music rather than a simple tone, the sustained low-frequency energy that can physically couple to tissues and membranes seems to matter most.
About the Pink Floyd clip, researchers described it as “atmospheric, warm, and spacious,” with rich harmonics typical of progressive rock. That blend—strong low-end foundation plus intricate texture—helps explain why this particular passage works as a test stimulus: it’s both physically resonant and musically complex.
To connect lab results to real biology, the team also included a human imaging component. In healthy volunteers, fMRI showed activation across frontal, temporal, and occipital regions in response to these low-frequency sounds, suggesting the pattern isn’t limited to petri dishes.
Why choose Pink Floyd for this research?
The brain’s blood–brain barrier remains a stubborn hurdle in neurology. It protects the mind from toxins but also blocks many therapeutic drugs aimed at brain disorders such as Alzheimer’s and Parkinson’s.
A practical delivery example is lipid nanoparticles (LNPs), the same platform used for delivering genetic material in COVID-19 vaccines. While LNPs can ferry cargo into cells, they frequently accumulate in the liver rather than reaching the brain.
Most strategies to bypass the barrier rely on aggressive approaches like modified nanoparticles, focused ultrasound, or surgical methods.
The Technion team asked: could sound help solve this problem?
Why a song? Sound isn’t just heard; it also vibrates and mechanically distorts cell membranes. This mechanical action—sonoporation—can temporarily create openings that allow nanoparticles to enter cells that would otherwise resist them.
To gauge broader biological impact, the researchers also examined mouse blood plasma with mass spectrometry. They observed shifts in proteins linked to cytoskeletal dynamics and cellular uptake, and a reduction in neutrophil counts, which may influence inflammatory processes.
Mora-Raimundo’s broader aim goes beyond the lab. Her personal motivation—her grandfather’s battle with Alzheimer’s—has shaped her belief that music can play a meaningful role in treating neurological disorders. She frames her approach as MINND: Music Input in Nanotechnology-based Treatments for Neurological Disorders, describing it as a “Pied Piper” guiding nanoparticles toward the brain.
Not the First Time Pink Floyd Has Appeared in Neuroscience
This isn’t the first time the song has been used in brain research. In 2023, UC Berkeley researchers recorded intracranial activity from 29 epilepsy patients using 2,668 electrodes as they listened to the track. They were able to reconstruct a recognizable version of the song from brain data, a step toward brain–computer interfaces for people who cannot speak due to paralysis or ALS.
As one Berkeley researcher noted, such a track provides both structure and richness that help map how the brain represents musical components across regions. For the Technion team, the same track’s strong low-frequency energy makes it a practical stimulus for experiments centered on mechanical effects on cells.
What Petri Dishes Can’t Tell You
The strongest neural effects appeared in brain regions involved in processing sound, such as the midbrain, thalamus, and related networks. Alzheimer’s pathology typically targets the hippocampus and cortex, so it remains unclear whether sound-guided delivery can reach the brain’s diseased hubs.
Crucially, the study did not test a disease model or deliver a drug to humans. The often-cited “tenfold increase” in expression reflects relative changes rather than absolute levels, and the human data were limited to imaging without therapeutic outcomes.
Translation to clinical practice is notoriously challenging. Indeed, more than 90% of neuropsychiatric drugs entering clinical trials fail. The researchers themselves emphasize that a deeper, more fundamental understanding of how music could facilitate brain drug delivery is needed before any clinical path can be confidently pursued.
The shared thread in this surprising coincidence is clear: two different scientific agendas—neuroscience mapping and targeted drug delivery—landed on the same track because it embodies two qualities researchers prize: a strong low-frequency foundation and rich, adaptable complexity. And regardless of what the future holds for therapies, the recordings themselves have already revealed a kind of information nobody was listening for before.
Would you say music should be explored more aggressively as a tool in medical treatment, or is this a case of appealing but premature hype? Share your take in the comments.
